Progress in understanding pseudoexfoliation syndrome and pseudoexfoliation-associated glaucoma

Canadian Journal of Ophthalmology

Volumn 42, Issue 5, 2007, Pages 657-658

  Damji, Karim F ^a  

^a UNIVERSITY OF OTTAWA EYE INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE ASSOCIATION; EDITORIAL; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; PREVALENCE; PSEUDOEXFOLIATION; RISK FACTOR;

EID: 36348942819     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.3129/I07-158     Document Type: Editorial

References (20)

1. Lindberg JG. Clinical investigations on depigmentation of the pupillary border and translucency of the iris. Acta Ophthalmol 1989;67(Suppl 190):1-96.
2. Tarkkanen A, Kivela T. John G. Lindberg and the discovery of exfoliation syndrome. Acta Ophthalmol Scand 2002;80:151-74.
3. Schlötzer-Schrehardt U, Koca M, Naumann GOH, Volkholz H. Pseudoexfoliation syndrome: ocular manifestation of a systemic disorder? Arch Ophthalmol 1992;110:1752-6.
4. Streeten BW, Li Z-Y, Wallace RN, Eagle RC, Keshgegian AA. Pseudoexfoliative fibrillopathy in visceral organs of a patient with pseudoexfoliation syndrome. Arch Ophthalmol 1992;110:1757-62.
5. Ritch R. Exfoliation syndrome: the most common identifiable cause of open-angle glaucoma. J Glaucoma 1996;3:176-8.
6. Ringvold A. Epidemiology of the pseudoexfoliation syndrome. Acta Ophthalmol Scand 1999;77:371-5.
7. Ritch R, Schlötzer-Schrehardt U. Exfoliation syndrome. Surv Ophthalmol 2001;45:265-315.
8. Naumann GOH, Schlötzer-Schrehardt U, Küchle M. Pseudoexfoliation syndrome for the comprehensive ophthalmologist: intraocular and systemic manifestations. Ophthalmology 1998;105:951-68.
9. Mitchell P, Wang JJ, Smith W. Association of pseudoexfoliation syndrome with increased vascular risk. Am J Ophthalmol 1997;124:685-7.
10. Yuksel N, Anik Y, Altintas O, Onur I, Caglar Y, Demirci A. Magnetic resonance imaging of the brain in patients with pseudoexfoliation syndrome and glaucoma. Ophthalmologica 2006;220(2):125-30.
11. Schlötzer-Schrehardt U, Naumann GOH. Ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol 2006;141:921-37.
12. Damji KF, Bains HS, Stefansson E, et al. Is pseudoexfoliation syndrome inherited? A review of genetic and nongenetic factors and a new observation. Ophthalmic Genet 1998;19:175-85.
13. Thorleifsson G, Magnusson KP, Sulem P, et al. Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science 2007; http://www.sciencemag.org/cgi/content/abstract/1146554. Published August 9, 2007. Accessed August 9, 2007.
14. Damji KF, Behki R, Wang L, for the Target IOP Workshop participants. Canadian perspectives in glaucoma management: setting target intraocular pressure range. Can J Ophthalmol 2003;38:189-97.
15. Konstas AG, Hollo G, Irkec M, et al. Diurnal IOP control with bimatoprost vs latanoprost in exfoliative glaucoma: a crossover, observer-masked, three-centre study. Br J Ophthalmol 2007;91(6):757-60.
16. Threlkeld AB, Hertzmark E, Sturm RT. Comparative study of the efficacy of argon laser trabeculoplasty for exfoliation and primary open-angle glaucoma. J Glaucoma 1996;5:311-6.
17. Damji KF, Bovell AM, Hodge WG, et al. Selective laser trabeculoplasty vs. argon laser trabeculoplasty: results from a 1-year randomized clinical trial. Br J Ophthalmol 2006;90(12):1490-4.
18. Damji KF, Konstas AGP, Liebmann JM, et al. Intraocular pressure following phacoemulsification in patients with and without exfoliation syndrome: a two year prospective study. Br J Ophthalmol 2006;90(8):1014-8.
19. Behki R, Damji KF, Crichton A, for the CCT Workshop participants. Canadian perspectives in glaucoma management: the role of central corneal thickness. Can J Ophthalmol 2007;42(1):66-74.
20. Hepsen IF, Yaǧci R, Keskin U. Corneal curvature and central corneal thickness in eyes with pseudoexfoliation syndrome. Can J Ophthalmol 2007;42(5):677-80.